$542M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | ABIVAX SA Abivax Sa | 516,447 | −14.0% | $69M | 12.7% |
| 2 | INSM Insmed Inc | 589,052 | −6.3% | $63M | 11.6% |
| 3 | TRVI Trevi Therapeutics Inc | 2.2M | +9.8% | $41M | 7.6% |
| 4 | BRIGHTSPRING HEALTH SVCS INC Brightspring Health Svcs Inc | 517,315 | +861.6% | $36M | 6.7% |
| 5 | RVMD Revolution Medicines Inc | 185,390 | +48.3% | $35M | 6.4% |
| 6 | ARGX Argenx Se | 29,739 | +0.0% | $28M | 5.1% |
| 7 | ALKS Alkermes Plc | 448,964 | — | $24M | 4.3% |
| 8 | TVTX Travere Therapeutics Inc | 339,033 | +379.5% | $19M | 3.6% |
| 9 | AZN Astrazeneca Plc | 98,376 | +3.1% | $19M | 3.4% |
| 10 | NAMS Newamsterdam Pharma Company | 503,936 | +0.0% | $17M | 3.2% |
| 11 | DNTH Dianthus Therapeutics Inc | 162,990 | +0.0% | $16M | 2.9% |
| 12 | DGX Quest Diagnostics Inc | 65,122 | +59.5% | $14M | 2.5% |
| 13 | IONS Ionis Pharmaceuticals Inc | 144,376 | +0.0% | $11M | 2.1% |
| 14 | EYPT Eyepoint Inc | 767,098 | +0.0% | $11M | 2.0% |
| 15 | ALMS Alumis Inc | 278,546 | −14.3% | $8M | 1.4% |
| 16 | VKTX Viking Therapeutics Inc | 180,731 | +0.0% | $7M | 1.3% |
| 17 | CELC Celcuity Inc | 59,316 | +280.8% | $6M | 1.1% |
| 18 | CYTK Cytokinetics Inc | 70,700 | +333.7% | $6M | 1.1% |
| 19 | MRK Merck & Co Inc | 46,700 | +0.0% | $6M | 1.1% |
| 20 | RAPP Rapport Therapeutics Inc | 138,508 | +0.0% | $6M | 1.1% |
| 21 | JNJ Johnson & Johnson | 22,600 | +0.0% | $6M | 1.1% |
| 22 | GH Guardant Health Inc | 38,100 | — | $6M | 1.1% |
| 23 | ABSI Absci Corporation | 464,444 | — | $5M | 1.0% |
| 24 | SRRK Scholar Rock Hldg Corp | 96,285 | +0.0% | $5M | 1.0% |
| 25 | SION Sionna Therapeutics Inc | 119,741 | +0.0% | $5M | 1.0% |
| 26 | ASND Ascendis Pharma A/S | 17,740 | — | $5M | 0.9% |
| 27 | ROIV Roivant Sciences Ltd | 129,800 | +0.0% | $5M | 0.8% |
| 28 | PALI Palisade Bio Inc | 2.0M | +0.0% | $4M | 0.8% |
| 29 | EWTX Edgewise Therapeutics Inc | 98,800 | +50.8% | $4M | 0.7% |
| 30 | BIIB Biogen Inc | 18,437 | +0.0% | $4M | 0.7% |
| 31 | XENE Xenon Pharmaceuticals Inc | 65,000 | +0.0% | $4M | 0.7% |
| 32 | BLTE Belite Bio Inc | 24,989 | +0.0% | $4M | 0.7% |
| 33 | MLYS Mineralys Therapeutics Inc | 137,800 | +0.0% | $4M | 0.7% |
| 34 | PROK Prokidney Corp | 1.8M | +0.0% | $4M | 0.7% |
| 35 | ELVN Enliven Therapeutics Inc | 72,100 | +245.0% | $4M | 0.7% |
| 36 | ORKA Oruka Therapeutics Inc | 33,400 | — | $3M | 0.6% |
| 37 | PTGX Protagonist Therapeutics Inc | 22,951 | +0.1% | $3M | 0.5% |
| 38 | UTHR United Therapeutics Corp Del | 5,000 | +0.0% | $3M | 0.5% |
| 39 | DRUG Bright Minds Biosciences Inc | 38,407 | +0.0% | $3M | 0.5% |
| 40 | KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl | 29,200 | +0.0% | $2M | 0.3% |
| 41 | CMPX Compass Therapeutics Inc | 383,200 | — | $839,208 | 0.2% |
| 42 | PRAX Praxis Precision Medicines I | 2,500 | +0.0% | $836,975 | 0.2% |
| 43 | KOD Kodiak Sciences Inc | 17,019 | +0.0% | $663,060 | 0.1% |
| 44 | TENX Tenax Therapeutics Inc | 42,080 | +0.0% | $612,264 | 0.1% |
| 45 | NUVALENT INC Nuvalent Inc | 4,900 | +0.0% | $605,150 | 0.1% |
| 46 | PEPG Pepgen Inc | 205,324 | +0.0% | $369,583 | 0.1% |
| 47 | SYRE Spyre Therapeutics Inc | 4,000 | — | $355,120 | 0.1% |